Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 203.34%51.17K | 301.42%78.64K | 208.33%70.27K | 40.41%109.87K | 107.50%50.62K | -2.88%16.87K | 14.86%19.59K | 17.30%22.79K | -80.04%78.25K | -59.10%24.4K |
| Selling and administrative expenses | 57.14%13.75K | 341.93%50.49K | 360.00%40.25K | 75.41%68.43K | 209.53%39.51K | 0.00%8.75K | 30.57%11.43K | 0.00%8.75K | -52.29%39.01K | -72.12%12.76K |
| -Selling and marketing expense | --5K | --30K | --31.5K | 543.49%3.21K | --3.21K | --0 | --0 | --0 | -96.32%499 | ---- |
| -General and administrative expense | 0.00%8.75K | 79.35%20.49K | 0.00%8.75K | 69.34%65.22K | 195.94%36.3K | 0.00%8.75K | 30.57%11.43K | 0.00%8.75K | -43.54%38.52K | -70.24%12.27K |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other operating expenses | 360.93%37.42K | 244.75%28.15K | 113.81%30.02K | 5.61%41.44K | -4.46%11.11K | -5.81%8.12K | -1.70%8.17K | 31.49%14.04K | -16.59%39.24K | -16.14%11.63K |
| Operating profit | -203.34%-51.17K | -301.42%-78.64K | -208.33%-70.27K | -40.41%-109.87K | -107.50%-50.62K | 2.88%-16.87K | -14.86%-19.59K | -17.30%-22.79K | 80.04%-78.25K | 59.10%-24.4K |
| Net non-operating interest income (expenses) | -21.03%-328 | 13.36%-227 | -14.80%-287 | -0.60%-1.01K | 15.36%-226 | -15.32%-271 | -3.97%-262 | 0.00%-250 | 0.10%-1K | 2.55%-267 |
| Total other finance cost | 21.03%328 | -13.36%227 | 14.80%287 | 0.60%1.01K | -15.36%226 | 15.32%271 | 3.97%262 | 0.00%250 | -0.10%1K | -2.55%267 |
| Other net income (expenses) | 92.83%-17 | 0 | -270.00%-17 | -253.90%-237 | -93.75%-62 | |||||
| Gain on sale of security | ---- | ---- | ---- | 92.83%-17 | --0 | -270.00%-17 | ---- | ---- | -253.90%-237 | -93.75%-62 |
| Income before tax | -200.46%-51.5K | -297.27%-78.87K | -206.23%-70.56K | -39.51%-110.9K | -105.72%-50.86K | 2.59%-17.14K | -13.50%-19.85K | -17.06%-23.04K | 79.76%-79.49K | 58.76%-24.72K |
| Income tax | 0 | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -200.46%-51.5K | -297.27%-78.87K | -206.23%-70.56K | -39.51%-110.9K | -105.72%-50.86K | 2.59%-17.14K | -13.50%-19.85K | -17.06%-23.04K | 79.76%-79.49K | 58.76%-24.72K |
| Net income continuous operations | -200.46%-51.5K | -297.27%-78.87K | -206.23%-70.56K | -39.51%-110.9K | -105.72%-50.86K | 2.59%-17.14K | -13.50%-19.85K | -17.06%-23.04K | 79.76%-79.49K | 58.76%-24.72K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -200.46%-51.5K | -297.27%-78.87K | -206.23%-70.56K | -39.51%-110.9K | -105.72%-50.86K | 2.59%-17.14K | -13.50%-19.85K | -17.06%-23.04K | 79.76%-79.49K | 58.76%-24.72K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -200.46%-51.5K | -297.27%-78.87K | -206.23%-70.56K | -39.51%-110.9K | -105.72%-50.86K | 2.59%-17.14K | -13.50%-19.85K | -17.06%-23.04K | 79.76%-79.49K | 58.76%-24.72K |
| Diluted earnings per share | -100.00%-0.002 | -200.00%-0.003 | -200.00%-0.003 | -25.00%-0.005 | -100.00%-0.002 | 0.00%-0.001 | 0.00%-0.001 | 0.00%-0.001 | 78.95%-0.004 | 66.67%-0.001 |
| Basic earnings per share | -100.00%-0.002 | -200.00%-0.003 | -200.00%-0.003 | -25.00%-0.005 | -100.00%-0.002 | 0.00%-0.001 | 0.00%-0.001 | 0.00%-0.001 | 78.95%-0.004 | 66.67%-0.001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.